首页> 外文期刊>Reviews in medical microbiology >Heat shock protein A of Helicobacter pylori: a promising vaccine candidate
【24h】

Heat shock protein A of Helicobacter pylori: a promising vaccine candidate

机译:幽门螺杆菌热休克蛋白A:有希望的候选疫苗

获取原文
获取原文并翻译 | 示例
       

摘要

Helicobacter pylori (H. pylori) is a spiral Gram-negative microaerophilic bacterium colonizing the human gastric mucosa. Infection with H. pylori has been recognized as the leading cause of specific gastroduodenal diseases. Because eradication requires treatment with multidrug regimens, controlling this global problem by vaccination is attractive. Extensive studies have demonstrated the feasibility of both prophylactic and therapeutic immunizations. However, most efforts have so far achieved limited success. This is partly due to the fact that neither an optimal composition of protective antigens nor the major protective immune mechanisms in humans have been identified. In this review, we describe the properties of heat shock protein A (HspA), such as its structural conservation and good immunogenicity, as one of the candidate antigens with most potential and its inclusion in an H. pylori vaccine.
机译:幽门螺杆菌(H. pylori)是一种螺旋的革兰氏阴性微需氧细菌,定居于人的胃粘膜。幽门螺杆菌感染已被认为是特定胃十二指肠疾病的主要原因。由于根除需要多种药物治疗,因此通过疫苗接种控制这一全球性问题很有吸引力。广泛的研究证明了预防性和治疗性免疫的可行性。但是,迄今为止,大多数努力都取得了有限的成功。这部分是由于尚未确定人体内保护性抗原的最佳组成或主要的保护性免疫机制这一事实。在这篇综述中,我们描述了热休克蛋白A(HspA)的特性,例如其结构保守性和良好的免疫原性,作为最有潜力的候选抗原之一,并将其​​包含在幽门螺杆菌疫苗中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号